Idexx Laboratories (IDXX) Net Margin (2009 - 2026)

Idexx Laboratories has reported Net Margin for 18 years, with the latest figure at 27.82% in Q2 2026.

• On a quarterly basis, Net Margin rose 132.0% year-over-year to 27.82% in Q2 2026; TTM through Jun 2026 was 25.03%, a 62.0% increase from a year earlier, with the FY2025 full-year figure at 24.62%, up 184.0% from the prior year.
• Net Margin was 27.82% for Q2 2026 at Idexx Laboratories, up from 24.41% in the prior quarter.
• The five-year high for Net Margin was 27.82% in Q2 2026, with the low at 15.34% in Q2 2022.
• Average Net Margin over 5 years is 23.05%, with a median of 23.47% recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Net Margin sank 919 bps in 2022, then jumped 843 bps in 2023.
• Over 5 years, Net Margin stood at 20.78% in 2022, then increased by 4 bps to 21.58% in 2023, then climbed by 5 bps to 22.65% in 2024, then gained by 0 bps to 22.76% in 2025, then advanced by 22 bps to 27.82% in 2026.
• The last three Net Margin figures came in at 27.82% (Q2 2026), 24.41% (Q1 2026), and 22.76% (Q4 2025), per Business Quant data.